Zobrazeno 1 - 10
of 34
pro vyhledávání: '"J. Stuart Ferriss"'
Publikováno v:
Obstetrics and Gynecology International, Vol 2014 (2014)
Objective. To assess the effectiveness and toxicity of carboplatin concurrent with pelvic external beam radiation and low-dose rate brachytherapy and to assess the impact that adherence to the treatment plan has on outcomes. Methods. Retrospective ch
Externí odkaz:
https://doaj.org/article/94fd0093a7214b38a54ed4f9b8186646
Autor:
Lauren Montemorano, Connor C Wang, Ankitha Madde, J Stuart Ferriss, Bunja J Rungruang, Brittany A Davidson, Ryan J Spencer
Publikováno v:
Gynecologic Oncology Reports, Vol 48, Iss , Pp 101216- (2023)
Objective: Virtual Gynecologic Oncology fellowship recruitment has altered how candidates and programs exchange information. This study analyzes programs’ web-based content and the priorities of fellowship candidates. Methods: Web-based materials o
Externí odkaz:
https://doaj.org/article/e4f444040c934eac97741ff4d07edc45
Autor:
Melissa H, Lippitt, Emily S, Johnson, Anja S, Frost, Sharon D, Thompson, Payam K, Kashi, Anna L, Beavis, Amanda N, Fader, J Stuart, Ferriss, Rebecca L, Stone, Stephanie L, Wethington
Publikováno v:
Journal of the American College of Surgeons. 235:306-314
Perioperative venous thromboembolism (VTE) is a significant cause of morbidity and mortality after gynecologic cancer surgery. Here we report a quality improvement intervention to increase perioperative VTE chemoprophylaxis compliance.All operations
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0bbfa4ff326b2ad0300b1b49828a548
https://doi.org/10.1097/xcs.0000000000000253
https://doi.org/10.1097/xcs.0000000000000253
Publikováno v:
International Journal of Gynecologic Cancer. 31:1165-1174
The incidence and mortality rates from endometrial cancer continue to increase worldwide, while rates in most other cancers have either plateaued or declined considerably. Uterine serous carcinoma represents a fraction of all endometrial malignancies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::276ee308f777f9170750dc214cb75ee5
https://doi.org/10.1136/ijgc-2021-002753
https://doi.org/10.1136/ijgc-2021-002753
Autor:
Shari Damast, Molly Klein, Omar Najjar, Joan Tymon-Rosario, Britt K. Erickson, Alessandro D. Santin, Adriana Blakaj, Rebecca L. Stone, Michelle M Dolan, J. Stuart Ferriss, Ashley Cimino-Mathews, Maryam Shahi, Amanda N. Fader, Natalia Buza, Mahmoud A. Khalifa
Publikováno v:
Gynecologic Oncology. 159:17-22
Background Human epidermal growth factor receptor 2 (HER2) has emerged as an important prognostic and therapeutic target in advanced stage and recurrent uterine serous carcinoma (USC). The significance of tumoral HER2 expression in early-stage diseas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::52adc17138b7e93ef0a061e7c9c33a3f
https://doi.org/10.1016/j.ygyno.2020.07.016
https://doi.org/10.1016/j.ygyno.2020.07.016
Autor:
J. Stuart Ferriss, Jeanine N. Staples, Shweta N. Patel, Christine Garcia, Linda R. Duska, Lindsay Chatfield
Publikováno v:
Gynecologic Oncology. 157:323-328
Objectives Given the disparity that exists in enrollment of minorities to oncology clinical trials, the objective of our study was to assess whether race is associated with willingness to participate in gynecologic oncology clinical trials in a rural
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4499574d725fe5808d57a5e3d7b528ca
https://doi.org/10.1016/j.ygyno.2020.01.040
https://doi.org/10.1016/j.ygyno.2020.01.040
Autor:
Barbara M. Norquist, Danielle Enserro, Bradley J. Monk, Michael A. Bookman, Matthew P. Boente, John K. Chan, Robert L. Coleman, Robert A. Burger, Michael J. Birrer, Philip J. DiSaia, Thomas J. Herzog, Krishnansu S. Tewari, Benjamin E. Greer, Helen Q. Huang, Howard D. Homesley, Elizabeth M. Swisher, Carlos Bais, Mark F. Brady, Leslie M. Randall, C. Ye, Larry J. Copeland, Sharon X. Liang, J. Stuart Ferriss, Carol Aghajanian, Robert S. Mannel, Gini F. Fleming, Jeffrey M. Fowler
Publikováno v:
J Clin Oncol
PURPOSE We report the final, protocol-specified analysis of overall survival (OS) in GOG-0218, a phase III, randomized trial of bevacizumab in women with newly diagnosed ovarian, fallopian tube, or primary peritoneal carcinoma. METHODS A total of 1,8
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ca405a5ed9df8156bdd64185764ea1e
https://doi.org/10.1200/jco.19.01009
https://doi.org/10.1200/jco.19.01009
Autor:
Steve Rose, Christine Walsh, Renata R. Urban, Abdulrahman K. Sinno, Ryan J. Spencer, Shitanshu Uppal, Bunja Rungruang, Linda R. Duska, J. Stuart Ferriss
Publikováno v:
Gynecologic Oncology
In approximately ten months' time, the novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has infected over 34 million people and caused over one million deaths worldwide. The impact of this virus on our health, relation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::462be8627c892c39e6df37ea67107031
Autor:
Alison Brooks Heinzman, Jessica L. Bienstock, J. Stuart Ferriss, Anja S. Frost, Danielle Patterson, Jaime Friel Blanck, Rita Tsai, Kristen Patzkowsky
Publikováno v:
Journal of Minimally Invasive Gynecology
Objective : To collect, summarize, and evaluate the currently available intraoperative rating tools used in abdominal minimally invasive gynecologic surgery (MIGS). Data Sources : Medline, Embase, and Scopus databases from January 1, 2000 to May 12,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e5cfe14343f11c757ea0a9de1f4ecc0
https://pubmed.ncbi.nlm.nih.gov/33086146
https://pubmed.ncbi.nlm.nih.gov/33086146
Autor:
J Stuart Ferriss, Youngchul Kim, Linda Duska, Michael Birrer, Douglas A Levine, Christopher Moskaluk, Dan Theodorescu, Jae K Lee
Publikováno v:
PLoS ONE, Vol 7, Iss 2, p e30550 (2012)
Despite advances in radical surgery and chemotherapy delivery, ovarian cancer is the most lethal gynecologic malignancy. Standard therapy includes treatment with platinum-based combination chemotherapies yet there is no biomarker model to predict the
Externí odkaz:
https://doaj.org/article/b4e517ff81be439084a9c96d1bf1fb21